Phenylalanine hydroxylase activity is present in the liver of human fetuses after the 8th week of gestation, and activities similar to those found in liver from adult control subjects are reached at around the 13th fetal week. The mean enzyme activity in fetal liver after the 13th week of gestation was 107 pmoles tyrosine formed per g protein per hr, and 130 jumoles in livers from adult control subjects. In premature infants soon after birth the mean enzyme activity was 67 /^moles tyrosine formed. This difference from the level of activity in fetuses could be due to loss of activity during the 1-3-hr delay in obtaining liver samples after death. When the pteridine cofactor was omitted from the enzyme assay system only very low activity was found in the livers of fetuses which were studied. Tyrosine was formed when isolated fetal livers were perfused with phenylalanine. The K m for phenylalanine hydroxylase from the liver of human fetuses was 9 X 10~4 M and for liver from adults was 1 X 10~3 M. Thus, the human fetus and immature newborn infant do not lack phenylalanine hydroxylase in the liver.
Introduction
In liver from adult mammals, tyrosine is formed by a complex enzyme system which converts the essential amino acid, phenylalanine, to tyrosine. This system consists of several enzymes and cofactors and the final reaction forming tyrosine requires the enzyme, phenylalanine hydroxylase (EC. 1.99.1.2), and a tetrahydropterin cofactor [8] . Four reports concerning the activity of phenylalanine hydroxylase during human development appear in the literature. Kenney and Kretchmer [10] reported the absence of the enzyme in one premature infant studied at necropsy, Ryan and Orr [16] reported the formation of some 14 C-tyrosine after postmortem injection of 14 C-phenylalanine into the umbilical vein of 22-week-24-week-old fetuses. During the course of the present study, Friedman and Kaufman [4] reported the presence of phenylalanine hydroxylase activity in the liver of one 23-week-old human fetus after storage of the liver for 4 weeks at -80°, and Jakubovic [6] also found phenylalanine hy-RAIHA droxylase present in the liver of seven human fetuses of between 11 and 20 weeks gestational age. In the present study the phenylalanine hydroxylase activity has been studied in liver from fetuses, neonates, and adult humans, and the tyrosine-forming capacity of isolated liver from human fetuses has been investigated.
Material and Methods
The phenylalanine hydroxylase activity was studied in 18 fresh livers from human fetuses (2.0-21.0 cm crownrump length), obtained by therapeutic abortion, in five premature neonates who died between 1 and 10 days after birth and in whom the liver sample was obtained 3 hr or less after death. The control material (3) 54 (1) 90 (1) 1 Numbers in parentheses indicate the time, in hours, after death at which the liver samples were excised.
consists of liver tissue obtained by abdominal surgery from adult patients of varying ages. The liver tissue was homogenized in 0.15 M KC1 and certifuged for 20 min at 6000 x g. The supernatant fluid was used for the enzyme assay. Phenylalanine hydroxylase activity was measured immediately by a modification of the methods described by Kaufman [7] and Bublitz [3] . The assay contained the following components (in micromoles): potassium phosphate, pH 6.8, 30; L-phenylalanine-14 C, 0.4 (0.2 //.Ci); dimethyltetrahydropteridine, 0.12; dithiothreitol, 2; 0.01-0.05 ml liver extract and water to a final volume of 0.2 ml. Tyrosine formation was assayed according to the method described by Kaufman [7] . The soluble protein concentration was measured [14] and enzyme activity was expressed as micromoles tyrosine formed per hour per gram soluble protein. In addition to these enzymatic studies, two isolated livers from fetuses with a crown-rump length of 11 and 17 cm were perfused with L-phenylalanine-14 C using the methods described by Kekomaki et al. [9] , and the tyrosine formation was measured.
Results
The in vitro studies on phenylalanine hydroxylase using an excess of reduced pteridine cofactor showed that liver from human fetuses contained measurable activity after the 8th week of gestation and values similar to those found in the adult control livers were reached at about 13 weeks (Table I) . When the pteridine cofactor was omitted from the assay system only very low phenylalanine activity was found in the fetal livers studied. Livers of neonates studied showed enzyme activities similar to those of the late fetal and adult livers regardless of birth weight and gestational age (Table I) . If liver samples were obtained later than 3 hours after death low enzyme activity was found.
Phenylalanine hydroxylase from the liver of human fetuses showed a rapid loss of activity when the liver was kept in room temperature after excision but could be stored at -80° over night without activity loss. Enzyme activity was reduced by about 25% in 3 hr and by 50% in 6 hr in tissue kept at room temperature. To see whether the enzyme in liver from human fetuses was different from that of liver from adults, the apparent K m values for phenylalanine were determined (Fig. 1) . The K m for phenylalanine hydroxylase of liver from human fetuses was 9 X 10~4 M and for liver from adults 1 X 10~3 M.
The two perfused livers from fetuses had a maximum formation of tyrosine 30 min after the start of the Phenylalanine hydroxylase in human liver perfusion which was 160 and 370 m^moles tyrosine/ min, respectively. At the concentration of substrate used in the medium, this was of the order of magnitude expected from the enzyme assay performed after the perfusion. The addition of tetrahydropteridine to the perfusate did not increase the formation of tyrosine.
Discussion
The phenylalanine hydroxylase activity found in the liver from a 23-week-old human fetus studied by Friedman and Kaufman [4] was 0.043 /xmoles/mg protein/ 30 min and corresponds well with the values found in fetal liver in the present study. It is thus evident that phenylalanine hydroxylase activity in liver from the human fetus is present much before term. The activities in the livers of the neonates who were studied after death were in general somewhat lower than those found in livers from fetuses in the late gestational stage and livers from adult control subjects. This could have been due to the l-hr-3-hr delay in obtaining liver samples, since it was demonstrated clearly that the enzyme activity was lost rapidly at room temperature.
Clinical studies of the phenylalanine-hydroxylating capacity of the neonate are somewhat conflicting. Thus, some studies have reported elevated levels of phenylalanine in the blood of many premature and some full-term neonates [5, 11, 15] , and decreased tolerance for phenylalanine loads in the normal neonate have been reported by Bremer and Neumann [1] . The elevated concentrations of phenylalanine in blood found in these infants have generally been explained as being due to a transient low activity of phenylalanine hydroxylase. On the other hand, Levine et al. [12] have demonstrated that after administration of phenylalanine there is an increased excretion of tyrosine in the urine in both premature and full-term neonates and Menkes and Avery [15] have found normal phenylalanine tolerance tests in premature neonates. Both findings are consistent with an active phenylalanine hydroxylase system.
Light et al. [13] observed moderate elevation of concentrations of phenylalanine in serum which was associated with a marked elevation of tyrosine in serum in 25% of infants with low birth weight. Levels of both phenylalanine and tyrosine in serum returned to normal when 100 mg ascorbic acid was administered daily. Distinction from patients with phenylketonuria was possible by recognition of elevated levels of tyrosine and by response to administered ascorbic acid. The present study indicates that phenylalanine hydroxylase is present in the liver from a very early stage of human development. The hyperphenylalaninemia observed in many premature infants for some time after birth should thus not be paralleled with a transient form of phenylketonuria (i.e., phenylalanine hydroxylase deficiency), but could rather be caused by excessive feeding of protein or to a relative deficiency of pteridine cofactor or dihydropteridine reductase. In the neonatal rat pterin cofactor and dihydropteridine reductase have been found to be low [2] . Snyderman [17] has been able to obtain data based on studies on weight gain and nitrogen retention which indicate that tyrosine is a dietary requirement for the majority of premature infants and that this requirement persists for several months after birth. These results suggest that the phenylalanine-hydroxylating system is deficient in the premature infant although the enzyme, phenylalanine hydroxylase, is present and suggest also that tyrosine might be an essential amino acid for the infant of low birth weight.
